CLINICAL_TRIALS
trial_result
· 2019-09-17
Clinical Trial Update: Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating proton therapy with FOLFIRINOX and losartan for pancreatic cancer; results status not provided.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN | Results posted: 2019-09-17